Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Omni-Biotic Balance is a multi-strain probiotic dietary supplement developed by Omni-Biotic (Institut AllergoSan). It is formulated with six scientifically tested bacterial strains: *Bifidobacterium animalis* W53, *Lactobacillus acidophilus* W55, *Lactobacillus salivarius* W57, *Enterococcus faecium* W54, *Lactococcus lactis* W58, and *Lactobacillus casei* W56, providing 2 billion colony-forming units (CFU) per dose. The supplement is designed to support immune function and restore gastrointestinal microbial balance, specifically targeting issues such as constipation, bloating, and the maintenance of healthy yeast levels (Candida). It is administered orally as a powder mixed with liquid.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Omni-Biotic Balance.